<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="38660">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02116322</url>
  </required_header>
  <id_info>
    <org_study_id>NA_00090101</org_study_id>
    <nct_id>NCT02116322</nct_id>
  </id_info>
  <brief_title>EUS-FNA of Solid Pancreatic Mass Lesions Using a Novel Corkscrew Technique: a Pilot Study</brief_title>
  <official_title>EUS-guided Fine Needle Tissue Acquisition of Solid Pancreatic Mass Lesions Using a Novel Corkscrew Technique: a Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johns Hopkins University</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This research is being done to investigate if a new technique to biopsy the pancreas will
      lead to a larger amount tissue material that can be analyzed. Investigators have called the
      technique the &quot;corkscrew&quot; technique and believe it will allow obtaining a larger biopsy
      sample during the endoscopic ultrasound examination. The corkscrew technique uses a
      clockwise rotational movement to drive the needle into the pancreatic mass (like a wine
      bottle opener twists and buries itself into a cork). It is believed that this will lead to a
      better biopsy sample than the usual way and therefore result in a higher chance of a
      diagnosis.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Anticipated">April 2016</completion_date>
  <primary_completion_date type="Anticipated">July 2015</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>Number of participants with adverse events as a measure of safety</measure>
    <time_frame>30 days</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Diagnostic yield of the FNA using corkscrew technique</measure>
    <time_frame>30 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>Diagnostic yield; as measured by the adequacy of the sample per on-site cytopathologist</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Pancreatic Cancer</condition>
  <arm_group>
    <arm_group_label>Pancreatic mass</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with pancreatic mass presenting for EUS-FNA</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>EUS-FNA with Corkscrew technique</intervention_name>
    <arm_group_label>Pancreatic mass</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Expect 19 G Flex needle</intervention_name>
    <arm_group_label>Pancreatic mass</arm_group_label>
    <other_name>Expect 19G Flex needle; Boston scientific</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  In-patients and out-patients between the age of 18 and 90 years with solid pancreatic
             masses presenting for EUS-FNTA

        Exclusion Criteria:

          -  Uncorrectable coagulopathy (INR &gt; 1.5)

          -  Uncorrectable thrombocytopenia (platelet &lt; 50,000)

          -  Uncooperative patients

          -  Pregnant women (women of childbearing age will undergo urine pregnancy testing, which
             is routine for all endoscopic procedures)

          -  Refusal to consent form

          -  Prior negative FNTA

          -  In situ metallic biliary stents

          -  Predominantly cystic lesions

          -  Inaccessible lesions to EUS
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mouen A Khashab, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Johns Hopkins University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mouen A Khashab, MD</last_name>
    <phone>443-287-1960</phone>
    <email>mkhasha1@jhmi.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ahmed A Messallam, MD</last_name>
    <phone>443-287-1960</phone>
    <email>amessal1@jhmi.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Johns Hopkins Hospital</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21287</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ahmed Messallam, MD</last_name>
      <email>amessal1@jhmi.edu</email>
    </contact>
    <contact_backup>
      <last_name>Mohamed El Zein, MD</last_name>
      <email>melzein1@jhmi.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Mouen A Khashab, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 20, 2014</lastchanged_date>
  <firstreceived_date>April 14, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Johns Hopkins University</investigator_affiliation>
    <investigator_full_name>Mouen Khashab</investigator_full_name>
    <investigator_title>Assistant professor of medicine</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Pancreatic Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
